75A50126F61006

CHEM 2207- EVALUATION OF LYOPHILIZED ELAPID VENOM ACETYLCHOLINESTERASE AND GLYCOPYRROLATE VERSUS CRITERION STANDARD TREATMENT ON NERVE AGENT MORTALITY (ELEVATE CST STUDY)

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	BARDA - ASPR / DAAPPO / BARDA DCMA
NAICS	541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC	AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicle	75A50122D00007
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$1.0M
Current contract value	$1.0M
Potential contract value / ceiling	$1.0M
Start date	Jul 16, 2026
Current end date	Dec 15, 2027
Potential end date	Dec 15, 2027
Latest award activity	Jul 14, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jul 14, 2026	0	$1.0M	CHEM 2207- EVALUATION OF LYOPHILIZED ELAPID VENOM ACETYLCHOLINESTERASE AND GLYCOPYRROLATE VERSUS CRITERION STANDARD TREATMENT ON NERVE AGENT MORTALITY (ELEVATE CST STUDY)

Estimated positioning window

Dec 15, 2026 – Jun 15, 2027

Recompete signal:

55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2027-12-15 (409 days from calculation): +25 points
121 historical awards in this buyer and category group: +15 points
1 recorded award transactions: +0 points
Latest award action: 2026-07-14: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.